Pertussis toxin activates adult and neonatal naive human CD4+ T lymphocytes

European Journal of Immunology

Volumn 36, Issue 7, 2006, Pages 1794-1804

  Tonon, Sandrine ^a   Badran, Bassam ^a   Benghiat, Fleur Samantha ^a   Goriely, Stanislas ^a   Flamand, Véronique ^a   Willard Gallo, Karen ^a   Willems, Fabienne ^a   Goldman, Michel ^a,b   De Wit, Dominique ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Institute for Medical Immunology   (Belgium)

Author keywords

Newborn; Pertussis toxin; T cell

Indexed keywords

CD4 ANTIGEN; CD40 LIGAND; CD45RA ANTIGEN; CELL SURFACE RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; MESSENGER RNA; MITOGENIC AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PERTUSSIS TOXIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVITY; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UPREGULATION;

EID: 33746266270     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535697     Document Type: Article

References (58)

1. Kaslow, H. R. and Burns, D. L., Pertussis toxin and target eukaryotic cells: Binding, entry, and activation. FASEB J. 1992. 6: 2684-2690.
2. McGuirk, P., Johnson, P. A., Ryan, E. J. and Mills, K. H., Filamentous hemagglutinin and pertussis toxin from Bordetella pertussis modulate immune responses to unrelated antigens. J. Infect. Dis. 2000. 182: 1286-1289.
3. Pizza, M., Giuliani, M. M., Fontana, M. R., Monaci, E., Douce, G., Dougan, G., Mills, K. H., Rappuoli, R. and Del Giudice, G., Mucosal vaccines: Non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 2001. 19: 2534-2541.
4. Su, S. B., Silver, P. B., Wang, P., Chan, C. C. and Caspi, R. R., Dissociating the enhancing and inhibitory effects of pertussis toxin on autoimmune disease. J. Immunol. 2003. 171: 2314-2319.
5. Tamura, S., Nakanishi, Y., Kojima, A., Otokawa, M., Uchida, N. and Sato, Y., Effects of pertussis toxin on delayed-type hypersensitivity responses and on the activity of suppressor T cells on the responses. Cell. Immunol. 1983. 81: 219-228.
6. Mu, H. H. and Sewell, W. A., Regulation of DTH and IgE responses by IL-4 and IFN-gamma in immunized mice given pertussis toxin. Immunology 1994. 83: 639-645.
7. Ryan, M., McCarthy, L., Rappuoli, R., Mahon, B. P. and Mills, K. H., Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: Adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28. Int. Immunol. 1998. 10: 651-662.
8. Shive, C. L., Hofstetter, H., Arredondo, L., Shaw, C. and Forsthuber, T. G., The enhanced antigen-specific production of cytokines induced by pertussis toxin is due to clonal expansion of T cells and not to altered effector functions of long-term memory cells. Eur. J. Immunol. 2000. 30: 2422-2431.
9. Roberts, M., Bacon, A., Rappuoli, R., Pizza, M., Cropley, I., Douce, G., Dougan, G. et al., A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9 K/129G, is an effective mucosal adjuvant for intranasally delivered proteins. Infect. Immun. 1995. 63: 2100-2108.
10. Hou, W., Wu, Y., Sun, S., Shi, M., Sun, Y., Yang, C., Pei, G. et al., Pertussis toxin enhances Th1 responses by stimulation of dendritic cells. J. Immunol. 2003. 170: 1728-1736.
11. Tonon, S., Goriely, S., Aksoy, E., Pradier, O., Del Guidice, G., Trannoy, E., Willems, F., et al., Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: Impaired responses in human newborns. Eur. J. Immunol. 2002. 32: 3118-3125.
12. Ausiello, C. M., Fedele, G., Urbani, F., Lande, R., Di Carlo, B. and Cassone, A., Native and genetically inactivated pertussis toxins induce human dendritic cell maturation and synergize with lipopolysaccharide in promoting T helper type 1 responses. J. Infect. Dis. 2002. 186: 351-360.
13. Kolb, J. P., Genot, E., Petit-Koskas, E., Paul-Eugene, N. and Dugas, B., Effect of bacterial toxins on human B cell activation. I. Mitogenic activity of pertussis toxin. Eur. J. Immunol. 1990. 20: 969-976.
14. Kong, A. S., and Morse, S. I., The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes. I. Proliferative response. J. Exp. Med. 1977. 145: 151-162.
15. Ho, M. K., Kong, A. S. and Morse, S. I., The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes. III. B-cell dependence for T-cell proliferation. J. Exp. Med. 1979. 149: 1001-1017.
16. Grenier-Brossette, N., Bourget, I., Breittmayer, J. P., Ferrua, B., Fehlmann, M. and Cousin, J. L., Pertussis toxin-induced mitogenesis in human T lymphocytes. Immunopharmacology 1991. 21: 109-119.
17. Latif, R., Kerlero de Rosbo, N., Amarant, T., Rappuoli, R., Sappler, G. and Ben-Nun, A., Reversal of the CD4(+)/CD8(+) T-cell ratio in lymph node cells upon in vitro mitogenic stimulation by highly purified, water-soluble S3-S4 dime of pertussis toxin. Infect. Immun. 2001. 69: 3073-3081.
18. Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K. and Akira, S., Cutting Edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the LPS gene product. J. Immunol. 1999. 162: 3749-3752.
19. Fleischer, B., Superantigens. Curr. Opin. Immunol. 1992. 4: 392-395.
20. Lewis, D. B., Yu, C. C., Meyer, J., English, B. K., Kahn, S. J. and Wilson, C. B., Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells. J. Clin. Invest. 1991. 87: 194-202.
21. Adkins, B., Williamson, T., Guevara, P. and Bu, Y., Murine neonatal lymphocytes show rapid early cell cycle and cell division. J. Immunol. 2003. 170: 4548-4556.
22. + T cells is due to limitations in both proximal and distal events of T cell activation. Int. Immunol. 2003. 15: 1461-1472.
23. Min, B., Legge, K. L., Bell, J. J., Gregg, R. K., Li, L., Caprio, J. C. and Zaghouani, H., Neonatal exposure to antigen induces a defective CD40 ligand expression that undermines both IL-12 production by APC and IL-2 receptor up-regulation on splenic T cells and perpetuates IFN-gamma-dependent T cell anergy. J. Immunol. 2001. 166: 5594-5603.
24. Durandy, A., De Saint Basile, G., Lisowska-Grospierre, B., Gauchat, J. F., Forveille, M., Kroczek, R. A., Bonnefoy, J. Y. and Fischer, A., Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns. J. Immunol. 1995. 154: 1560-1568.
25. Hori, S., Nomura, T. and Sakagushi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003. 299: 1057-1061.
26. Hassan, J., O'Neill, S., O'Neill, L. A., Pattison, U. and Reen, D. J., Signalling via CD28 of human naive neonatal T lymphocytes. Clin. Exp. Immunol. 1995. 102: 192-198.
27. Wakatsuki, A., Borrow, P., Rigley, K. and Beverley, P. C., Cell-surface bound pertussis toxin induces polyclonal T cell responses with high levels of interferon-gamma in the absence of interleukin-12. Eur. J. Immunol. 2003. 33: 1859-1868.
28. Winslow, M. M., Neilson, J. R. and Crabtree, G. R., Calcium signaling in lymphocytes. Curr. Opin. Immunol. 2003. 15: 299-307.
29. Rosoff, P. M., Walker, R. and Winberry, L., Pertussis toxin triggers rapid second messenger production in human T lymphocytes. J. Immunol. 1987. 139: 2419-2423.
30. + T lymphocytes during primary stimulation. Blood 2003. 102: 4608-4617.
31. Badran, B. M., Wolinsky, S. M., Burny, A. and Willard-Gallo, K. E., Identification of three NFAT binding motifs in the 5′-upstream region of the human CD3γ gene that differentially binds NFATc1, NFATc2, and NF-κB p50. J. Biol. Chem. 2002. 277: 47136-47148.
32. Badran, B. M., Kunstman, K., Stanton, J., Moschitta, M., Zerghe, A., Aki, H., Burny, A. et al., Transcriptional regulation of the human CD3γ gene: The TATA-less CD3γ promoter functions via an initiator and contiguous Sp binding elements. J. Immunol. 2005. 174: 6238-6249.
33. Macian, F., NFAT proteins: Key regulators of T-cell development and function. Nat. Rev. Immunol. 2005. 5: 472-484.
34. Hoey, T., Sun, Y. L., Williamson, K. and Xu, X., Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity 1995. 2: 461-472.
35. Sallusto, F., Lenig, D., Forster, R., Lipp, M. and Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999. 401: 708-712.
36. Splawski, J. B., Nishioka, J., Nishioka, Y. and Lipsky, P. E., CD40L is expressed and functional on activated neonatal T cells. J. Immunol. 1996. 156: 119-127.
37. + T regulatory cells. Eur. J. Immunol. 2006. 36: 671-680.
38. + T cells are a major source of lymphotoxin alpha. J. Immunol. 1999. 162: 3790-3794.
39. Millet, I. and Ruddle, N. H., Differential regulation of lymphotoxin (LT), lymphotoxin-beta (LT-beta), and TNF-alpha in murine T cell clones activated through the TCR. J. Immunol. 1994. 152: 4336-4346.
40. Yang, Y., Chang, J. F., Parnes, J. R. and Fathman, C. G., T cell receptor (TCR) engagement leads to activation-induced splicing of tumor necrosis factor (TNF) nuclear pre-mRNA. J. Exp. Med. 1998. 188: 247-254.
41. Acuto, O. and Michel, F., CD28-mediated co-stimulation: A quantitative support for TCR signalling. Nat. Rev. Immunol. 2003. 3: 939-951.
42. Rainsford, E. and Reen, D. J., Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation. Br. J. Haematol. 2002. 116: 702-709.
43. Li, H. and Wong, W. S., Mechanisms of pertussis toxin-induced myelomonocytic cell adhesion: Role of CD14 and urokinase receptor. Immunology 2000. 100: 502-509.
44. Kerfoot, S. M., Long, E. M., Hickey, M. J., Andonegui, G., Lapointe, B. M., Zanardo, R. C., Bonder, C. et al., TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J. Immunol. 2004. 173: 7070-7077.
45. Racke, M. K., Hu, W. and Lovett-Racks, A. E., PTX cruiser: Driving autoimmunity via TLR4. Trends Immunol. 2005. 26: 289-291.
46. Ford, M. L., Onami, T. M., Sperling, A. I., Ahmed, R. and Evavold, B. D., CD43 modulates severity and onset of experimental autoimmune encephalomyelitis. J. Immunol. 2003. 171: 6527-6533.
47. Corinti, S., Fanales-Belasio, E., Albanesi, C., Cavani, A., Angelisova, P. and Girolomoni, G., Cross-linking of membrane CD43 mediates dendritic cell maturation. J. Immunol. 1999. 162: 6331-6336.
48. Santana, M. A., Pedraza-Alva, G., Olivares-Zavaleta, N., Madrid-Marina, V., Horejsi, V., Burakoff, S. J. and Rosenstein, Y., CD43-mediated signals induce DNA binding activity of AP-1, NF-AT, and NFkappa B transcription factors in human T lymphocytes. J. Biol. Chem. 2000. 275: 31460-31468.
49. Witvliet, M. H., Vogel, M. L., Wiertz, E. J. and Poolman, J. T., Interaction of pertussis toxin with human T lymphocytes. Infect Immun. 1992. 60: 5085-5090.
50. Stewart, S. J., Prpic, V., Johns, J. A., Powers, F. S., Graber, S. E., Forbes, J. T. and Exton, J. H., Bacterial toxins affect early events of T lymphocyte activation. J. Clin. Invest. 1989. 83: 234-242.
51. Schmitz, M. L., Bacher, S. and Dienz, O., NF-κB activation pathways induced by T cell costimulation. FASEB J. 2003. 17: 2187-2193.
52. Mantel, P. Y., Ouaked, N., Ruckert, B., Karagiannidis, C., Welz, R., Blaser, K. and Schmidt-Weber, C. B., Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 2003. 176: 3593-3602.
53. Chuvpilo, S., Avots, A., Berberich-Siebelt, F., Glockner, J., Fischer, C., Kerstan, A., Escher, C. et al., Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes. J. Immunol. 1999. 162: 7294-7301.
54. Pizza, M., Covacci, A., Bartoloni, A., Perugini, M., Nencioni, L., De Magistris, M. T., Villa, L. et al., Mutants of pertussis toxin suitable for vaccine development. Science 1989. 246: 497-500.
55. Rappuoli, R., Rational design of vaccines. Nat. Med. 1997. 3: 374-376.
56. Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G. et al., Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994. 180: 83-93.
57. Van Lint, C., Amella, C. A. and Emiliani, S., Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. J. Virol. 1997. 71: 6113-6127.
58. Stordeur, P., Poulin, L. F., Craciun, L., Zhou, L., Schandene, L., de Lavareille, A., Goriely, S. and Goldman, M., Cytokine mRNA quantification by real-time PCR. J. Immunol. Methods 2002. 259: 55-64.